MTOR and type 2 diabetes mellitus: Although, further works are required to clarify the roles of O-GlcNAcylation on PI3K/AKT/mTOR regulation under normal physiological context, their interplay is highlighted by their associated dysregulation in several types of cancer, T2D, and cardiovascular and neurodegenerative diseases (Figure 2).